Webinar: Can we Predict which Endoscopists are More Likely to Miss Esophageal Adenocarcinoma?
September 9, 2025
Our Presenters
Sachin Wani, MD, FASGE, AGAF
Dr. Wani is the Katy O, and Paul M. Rady Endowed Chair in Esophageal Cancer Research and
a Professor of Medicine at the University of Colorado Anschutz Medical Campus specializing in
esophageal diseases and therapeutic endoscopy.
He has a long-standing research focus in the field of Barrett’s esophagus and esophageal adenocarcinoma.
Over the past 10 years, he has developed a successful track record of:
a) conducting epidemiologic studies that have defined the natural history of Barrett’s esophagus and Barrett’s associated dysplasia,
b) conducting studies that demonstrated the effectiveness and safety of endoscopic eradication therapies for management of Barrett’s esophagus-related dysplasia and esophageal adenocarcinoma, c) developing novel quality indicators and outcome metrics for endoscopic eradication therapies in Barrett’s esophagus developed by the Treatment with Resection and Endoscopic Ablation Techniques for Barrett’s esophagus (TREAT-BE) Consortium,
d) conducting studies to improve the effectiveness of current screening and surveillance strategies using devices such as the Cytosponge and advanced imaging techniques, and
e) authoring national GI society guidelines on endoscopic eradication therapy for Barrett’s-related neoplasia patients (American Society for Gastrointestinal Endoscopy – ASGE), Barrett’s esophagus with low-grade dysplasia (American Gastroenterological Association – AGA), and screening and surveillance in Barrett’s esophagus (ASGE).
Nicholas J. Shaheen, MD, MPH
Dr. Shaheen is the Bozymski-Heizer Distinguished Professor of Medicine. Co-Director, North Carolina Translational & Clinical Research Center (NC TraCS) and Senior Associate Dean for Clinical Research.
His clinical and research interests center on gastroesophageal reflux disease and pre-cancerous and cancerous conditions of the esophagus. He promotes early detection and treatment of cancer of the esophagus, including endoscopic treatment of Barrett’s esophagus, the only known precursor of Esophageal Adenocarcinoma.
His team is constantly working on better ways to treat these conditions, and we frequently ask our patients to consider being part of studies to help us better understand how to help patients with these problems. Dr. Shaheen has authored greater than 400 publications in these areas, including guidelines statements on Barrett’s esophagus, GERD, eosinophilic esophagitis and the use of endoscopy.
He has served as senior associate editor for the American Journal of Gastroenterology, and on multiple other editorial boards. He is currently principal investigator on multiple NIH grants investigating aspects of esophagus disease. He believes that through a combination of better early detection, better treatments, and careful post-treatment care, we can reduce the number of people who die from esophageal cancer.
Please take two minutes to complete this short survey to give us your feedback about the webinar.
Generous Sponsors that make ECAN’s Webinar Series possible
